SCHEMBL23680073

SCHEMBL23680073

Cc1cc(OC(=O)N2CCN(OCN)CC2)n(-c2ccccc2)n1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 2/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ ALDH1A1 P00352 3/20 0.41
▸ NTRK1 P04629 1/20 0.41
▸ TSHR P16473 2/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ MAPT P10636 2/20 0.40
▸ ATM Q13315 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ P2RY1 P47900 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ P2RY12 Q9H244 1/20 0.39
▸ TP53 P04637 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21845297 0.86 GAA (0.43) GAAKMT2AALDH1A1NTRK1TSHR
Hydrochloric Acid SCHEMBL21808300 0.85 GAA (0.42) GAAKMT2AALDH1A1NTRK1TSHR
SCHEMBL21808533 0.83 HRH3 (0.48) GAAKMT2AALDH1A1NTRK1TSHR
SCHEMBL23668147 0.83 NTRK1 (0.46) GAAKMT2AALDH1A1NTRK1TSHR
Hydrochloric Acid SCHEMBL21808492 0.82 HRH3 (0.47) GAAKMT2AALDH1A1NTRK1TSHR
SCHEMBL23668124 0.81 TSHR (0.52) GAAKMT2AALDH1A1NTRK1TSHR
SCHEMBL23668130 0.81 P2RY12 (0.43) GAAKMT2AALDH1A1NTRK1TSHR
SCHEMBL21808515 0.81 P2RY12 (0.43) GAAKMT2AALDH1A1NTRK1TSHR
SCHEMBL23668142 0.81 P2RY12 (0.43) GAAKMT2AALDH1A1NTRK1TSHR
SCHEMBL23668144 0.81 P2RY12 (0.43) GAAKMT2AALDH1A1NTRK1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3854787-A1 EDARAVONE PRODRUG COMPOUND AND PHARMACEUTICAL USE THEREOF IN TREATMENT OR ALLEVIATION OF NEURODEGENERATIVE OR MOTOR NEURON DISEASE J2H Biotech Inc. (KR) 2021-07-28 — — EP disclosed
Send feedback